{"address1": "1 Enterprise Drive", "address2": "Suite 430", "city": "Shelton", "state": "CT", "zip": "06484-4779", "country": "United States", "phone": "203 221 7381", "fax": "203 557 3023", "website": "https://www.intensitytherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lewis H. Bender M.A., M.B.A., M.S.", "age": 65, "title": "Founder, President, CEO & Chairman of the Board", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 597007, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Talamo CPA, M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 416930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Wesolowski CPA, M.B.A.", "age": 64, "title": "Principal Accounting Officer & Controller", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 260898, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James M. Ahlers", "age": 60, "title": "Executive Vice President of Corporate Finance", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 75088, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Schwartz M.D.", "title": "Executive Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.97, "open": 1.9749, "dayLow": 1.9, "dayHigh": 2.06, "regularMarketPreviousClose": 1.97, "regularMarketOpen": 1.9749, "regularMarketDayLow": 1.9, "regularMarketDayHigh": 2.06, "payoutRatio": 0.0, "forwardPE": -1.7457627, "volume": 19119, "regularMarketVolume": 19119, "averageVolume": 34606, "averageVolume10days": 60510, "averageDailyVolume10Day": 60510, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 31272654, "fiftyTwoWeekLow": 1.5, "fiftyTwoWeekHigh": 5.275, "fiftyDayAverage": 2.21608, "twoHundredDayAverage": 3.296045, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 28820746, "profitMargins": 0.0, "floatShares": 6856474, "sharesOutstanding": 15180900, "sharesShort": 51912, "sharesShortPriorMonth": 51513, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0034, "heldPercentInsiders": 0.40745, "heldPercentInstitutions": 0.17918, "shortRatio": 2.87, "shortPercentOfFloat": 0.0049, "impliedSharesOutstanding": 15180900, "bookValue": 0.193, "priceToBook": 10.673574, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -16268000, "trailingEps": -1.17, "forwardEps": -1.18, "52WeekChange": -0.54774976, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 2.06, "targetHighPrice": 15.0, "targetLowPrice": 4.0, "targetMeanPrice": 9.3, "targetMedianPrice": 8.5, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 2590000, "totalCashPerShare": 0.171, "totalDebt": 138000, "quickRatio": 1.476, "currentRatio": 1.916, "debtToEquity": 4.729, "returnOnAssets": -0.939, "returnOnEquity": -2.02338, "freeCashflow": -9538625, "operatingCashflow": -15220000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "INTS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -1.17, "epsForward": -1.18, "epsCurrentYear": -0.56, "priceEpsCurrentYear": -3.6785712, "fiftyDayAverageChange": -0.15608001, "fiftyDayAverageChangePercent": -0.07043067, "twoHundredDayAverageChange": -1.2360451, "twoHundredDayAverageChangePercent": -0.37500855, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-06-30", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": 4.5685234, "regularMarketPrice": 2.06, "shortName": "Intensity Therapeutics, Inc.", "longName": "Intensity Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1688131800000, "regularMarketChange": 0.089999914, "regularMarketDayRange": "1.9 - 2.06", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 34606, "fiftyTwoWeekLowChange": 0.55999994, "fiftyTwoWeekLowChangePercent": 0.3733333, "fiftyTwoWeekRange": "1.5 - 5.275", "fiftyTwoWeekHighChange": -3.2150002, "fiftyTwoWeekHighChangePercent": -0.6094787, "fiftyTwoWeekChangePercent": -54.774975, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_225412349", "displayName": "Intensity Therapeutics", "trailingPegRatio": null}